Inventory decreased 36.0%
Inventory changed -36.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed -36.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed +48.1% from the comparable as-filed period.
Operating income changed +44.7% from the comparable as-filed period.
Operating margin changed +1429 basis points from the comparable as-filed period.
Stock-based compensation changed +49.6% from the comparable as-filed period.
Cash & equivalents changed -11.8% from the comparable as-filed period.
Research & development changed -13.7% from the comparable as-filed period.
Revenue changed +4.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.